PF-868554

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-868554, covering 2014-01-03 to 2014-01-03. Get the full timeline:

Most recent: Clinical Trial Update: Study To Assess The Impact Of Hepatic Impairment On The Safety, Tolerability And Pharmacokinetics Of Single-Dose 200 Mg Of PF-868554 [Phase 1]

See pricing